Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Ewing Sarcoma

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Ewing Sarcoma in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, T1
Ohno, T1
Wakahara, K1
Nagano, A1
Kawai, G1
Saitou, M1
Takigami, I1
Matsuhashi, A1
Yamada, K1
Shimizu, K1
Lawlor, ER1
Scheel, C1
Irving, J1
Sorensen, PH1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Ewing Sarcoma

ArticleYear
Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma.
    Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Butadienes; Cell

2009
Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors.
    Oncogene, 2002, Jan-10, Volume: 21, Issue:2

    Topics: Artificial Gene Fusion; Bone Neoplasms; Butadienes; Cell Adhesion; Cell Division; Chromones; DNA-Bin

2002